Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look ...

Senate Republicans are plotting deeper Medicaid cuts to bankroll tax reforms, ditching previous plans to trim Medicare ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers ...

Amgen beat Q1 estimates with strong margins driven by Blincyto, Prolia, and standout Imdelltra growth, plus strength in ...

Cigna Group’s stock had a strong session, closing at $314.31 after a $4.11 surge that turned investor heads. The stock jumped 1.32% for the day, riding a wave of optimism and charting a course well ...

Earnings per share of $0.07, beating the estimated $0.03, showcasing stronger-than-expected profitability. Revenue of ...

For the second quarter of 2025, Chewy expects sales of $3.06 billion-$3.09 billion compared to the consensus of $3.03 billion ...

Chewy topped Q1 expectations with $3.12 billion in sales and 35 cents EPS, driven by subscription growth and rising customer ...

CVS Health, once thought of as the ugly duckling of the healthcare industry, is starting to turn things around. Read why CVS ...